Ex-OpenAI science head Kevin Weil launches startup with $215 million

Kevin Weil, the former OpenAI executive who led its AI-for-science efforts, has launched a startup with $215 million aimed at using AI to speed up a key step of drug development.

• OpenAI may merge ChatGPT and Codex usage limits2026-11-01
• AI smart glasses can answer 80% of SAT questions, study finds2026-11-01
• OpenAI internal model produced 722 math manuscripts2026-10-31
• OpenAI cuts funding target by $10B; valuation falls to $1.25T2026-10-31
• GPT-5.6 Sol beats Factorio on peaceful mode2026-10-31